Why is PTGX Up Today?
About Protagonist Therapeutics, Inc
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Overall Confidence: 75%
Based on news, social sentiment, options activity, and sector analysis
✅ Move Confirmation
UNCONFIRMED - Low volume suggests this move may not be sustainable.
📍 Sector Context
PHARMACEUTICAL PREPARATIONS sector: -0.5%
Market Comparison
🔔 Get PTGX Alerts
We'll notify you when PTGX's trend changes or a new signal fires.
Data refreshes every 30 minutes during market hours
Historical Context
PTGX has moved more than 3.0% up on 32 occasions in the past year.
Frequently Asked Questions
Why is PTGX stock up today?
Options traders are heavily buying calls on PTGX, with 94% of volume in calls. This suggests bullish institutional positioning.
Is PTGX stock a buy or sell right now?
Based on current analysis, PTGX shows 75% confidence in today's move. Volume is low which does not confirm the trend. View full buy/sell analysis →
What is the PTGX stock price target?
PTGX is currently trading at $148.09. Based on today's momentum, the expected short-term range is $145.13 - $152.53. See long-term price prediction →
Will PTGX stock continue rising?
Our analysis shows a 45% probability that PTGX's move continues in the next 1-3 days. Key level to watch: $155.49 (resistance).
Is PTGX stock oversold or overbought?
PTGX's RSI (Relative Strength Index) is currently at 53.4. This shows bullish momentum - the stock has positive momentum but isn't overextended yet.
What is the momentum for PTGX stock?
PTGX's 10-day momentum indicator is at -1.41. Negative momentum - the stock has mild downward pressure which may continue short-term.
Is PTGX outperforming or underperforming the market?
PTGX (+2.02%) is currently outperforming the market (+1.2% vs SPY). Today, the S&P 500 (SPY) is up 0.85%, and Nasdaq (QQQ) is up 0.87%.
What does MACD indicate for PTGX?
PTGX's MACD (1.03) is currently below the signal line (2.18), indicating a bearish trend. This technical signal suggests selling pressure is dominant. The trend strength (ADX: 20.8) is moderate.
Is PTGX in an uptrend or downtrend?
Based on moving average analysis, PTGX is in a mixed/transitional trend. The price and moving averages are not clearly aligned, suggesting a potential trend change or consolidation phase. 20-day SMA: $150.04, 50-day SMA: $142.86.
Check Why Another Stock is Moving
Enter any ticker symbol to see real-time analysis